Cibc World Market Inc. Decreases Stock Holdings in Cardinal Health, Inc. $CAH

Cibc World Market Inc. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 8.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,427 shares of the company’s stock after selling 2,381 shares during the quarter. Cibc World Market Inc.’s holdings in Cardinal Health were worth $3,834,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Latitude Advisors LLC boosted its stake in shares of Cardinal Health by 2.1% in the third quarter. Latitude Advisors LLC now owns 2,598 shares of the company’s stock valued at $408,000 after purchasing an additional 53 shares during the period. WESPAC Advisors LLC raised its holdings in Cardinal Health by 1.0% in the third quarter. WESPAC Advisors LLC now owns 6,644 shares of the company’s stock valued at $1,043,000 after acquiring an additional 63 shares in the last quarter. Kathmere Capital Management LLC boosted its stake in Cardinal Health by 1.6% during the 3rd quarter. Kathmere Capital Management LLC now owns 4,091 shares of the company’s stock valued at $642,000 after acquiring an additional 65 shares during the last quarter. Vermillion & White Wealth Management Group LLC increased its position in shares of Cardinal Health by 55.0% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 200 shares of the company’s stock worth $34,000 after purchasing an additional 71 shares during the last quarter. Finally, Woodward Diversified Capital LLC grew its stake in Cardinal Health by 4.0% in the third quarter. Woodward Diversified Capital LLC now owns 1,854 shares of the company’s stock worth $291,000 after purchasing an additional 72 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Price Performance

CAH stock opened at $220.72 on Monday. The company’s 50 day simple moving average is $208.84 and its 200-day simple moving average is $182.54. The firm has a market capitalization of $51.94 billion, a P/E ratio of 31.76, a P/E/G ratio of 1.42 and a beta of 0.64. Cardinal Health, Inc. has a 52-week low of $120.72 and a 52-week high of $230.81.

Cardinal Health (NYSE:CAH) last released its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.31 by $0.32. The company had revenue of $65.63 billion during the quarter, compared to the consensus estimate of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company’s revenue was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.93 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $2.04 dividend on an annualized basis and a yield of 0.9%. Cardinal Health’s dividend payout ratio (DPR) is 29.35%.

Key Headlines Impacting Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Analysts Set New Price Targets

CAH has been the topic of several research analyst reports. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. Barclays assumed coverage on shares of Cardinal Health in a report on Monday, December 8th. They set an “overweight” rating and a $243.00 target price on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Cardinal Health from $195.00 to $208.00 and gave the company a “hold” rating in a report on Tuesday, November 18th. Argus increased their price objective on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. Finally, Zacks Research upgraded Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $245.19.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.